Immune modulators as antiviral agents.
Immune modulators have exhibited some limited efficacy in the prevention or treatment of viral infection. Such agents have included transfer factor, thymosin, thymic humoral factors, levamisole, isoprinosine, immune RNA, young lymphocytes, vitamin C, and BCG. This article focuses on data that have examined clinical application of immune adjuvant therapy.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D006801:Humans; D007542:Inosine Pranobex / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D017710:Lymphocyte Transfusion; D012313:RNA / Q000276:immunology / Q000627:therapeutic use; D013951:Thymus Hormones / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use; D014777:Virus Diseases / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; C013674:RNA, immune; D013951:Thymus Hormones; D014165:Transfer Factor; D007978:Levamisole; D012313:RNA; D001205:Ascorbic Acid; D007542:Inosine Pranobex